Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2015

01-10-2015

Rapid normalization of vasculitis-induced left ventricular dysfunction related with multiple cardiac thrombi

Authors: Ignatios Ikonomidis, Konstantina Ntai, John Parissis, John Palios, Agathi-Rosa Vrettou, Ioannis Paraskevaidis, John Lekakis

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2015

Login to get access

Abstract

We present a young female patient admitted in the emergency department with pulmonary edema, severely impaired left ventricular function, and simultaneous intracardiac thrombi in left and right ventricle as well as in right atrium, at echocardiography. A magnetic resonance tomography showed excess myocardial tissue edema and diffuse gadolinium enhancement. Blood analysis showed an elevated eosinophils count. The patient showed a rapid normalization of left ventricular function as well as resolution of intracardiac thrombi and myocardial tissue edema 3 months after proper treatment with cyclophosphamide and steroids for Churg–Strauss syndrome.
Literature
1.
go back to reference Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum 33:1065–1067CrossRefPubMed Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis: introduction. Arthritis Rheum 33:1065–1067CrossRefPubMed
2.
go back to reference Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, Schett G, Zwerina J (2009) Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine 88:236–243CrossRefPubMed Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, Schett G, Zwerina J (2009) Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine 88:236–243CrossRefPubMed
3.
go back to reference Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P (1996) Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol 35:958–964CrossRefPubMed Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P (1996) Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol 35:958–964CrossRefPubMed
4.
go back to reference Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Tervaert JWC, Heymans S (2010) Arthritis Rheum 62:627–634PubMed Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Tervaert JWC, Heymans S (2010) Arthritis Rheum 62:627–634PubMed
Metadata
Title
Rapid normalization of vasculitis-induced left ventricular dysfunction related with multiple cardiac thrombi
Authors
Ignatios Ikonomidis
Konstantina Ntai
John Parissis
John Palios
Agathi-Rosa Vrettou
Ioannis Paraskevaidis
John Lekakis
Publication date
01-10-2015
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2015
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-014-1163-5

Other articles of this Issue 3/2015

Journal of Thrombosis and Thrombolysis 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.